Shanghai Pharmaceuticals Holding Co., Ltd (SHA:601607)

Market Cap	53.83B -11.6%
Revenue (ttm)	288.08B +4.4%
Net Income	5.81B +33.8%
EPS	1.56 +33.6%
Shares Out	3.71B
PE Ratio	10.18
Forward PE	11.09
Dividend	0.47 (2.92%)
Ex-Dividend Date	Jan 5, 2026

Volume	10,354,337
Open	16.11
Previous Close	16.11
Day's Range	15.90 - 16.13
52-Week Range	15.91 - 19.68
Beta	0.21
Analysts	Buy
Price Target	20.56 (+29.23%)
Earnings Date	Aug 28, 2026

About SHA:601607

Shanghai Pharmaceuticals Holding Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceutical and healthcare products in China and internationally. The company operates through four segments: Production, Distribution, Retail, and Others. It offers chemical and biological drugs, Chinese medicine, health care products, and medical devices to treat immunology, psychiatric and neurological, tumor, cardiovascular, digestive metabolism, psychoneurotic, neoplasm, respiratory system, and anti-infection diseases, as well as in...

• Industry: Medical Distribution
• Sector: Healthcare
• Founded: 1994
• Employees: 49,608
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 601607

Financial Performance

In 2025, SHA:601607's revenue was 283.58 billion, an increase of 3.03% compared to the previous year's 275.25 billion. Earnings were 5.72 billion, an increase of 25.74%.

Analyst Summary

According to 10 analysts, the average rating for 601607 stock is "Buy." The 12-month stock price target is ¥20.56, which is an increase of 29.23% from the latest price.

Price Target

¥20.56

(29.23% upside)

Analyst Consensus: Buy

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Jun 18, 2026

Data Sources Report a data error